Celldex Therapeutics, Inc. (CLDX)

VMware Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	17.14	28.36	34.81	29.43	39.14	43.84
Short-Term Investments	656.16	696.93	388.78	275.52	369.11	150.59
Cash & Short-Term Investments	673.29	725.28	423.6	304.95	408.25	194.42
Cash Growth	-18.27%	71.22%	38.91%	-25.30%	109.98%	201.98%
Receivables	1.06	0.7	2.63	0.35	0.17	1.8
Prepaid Expenses	19.4	21.18	5.47	12.39	2.42	1.62
Total Current Assets	693.76	747.16	431.69	317.69	410.84	197.84
Property, Plant & Equipment	8.12	8.24	6.64	7.75	6.52	7.26
Other Intangible Assets	27.19	27.19	27.19	27.19	27.19	30.69
Other Long-Term Assets	10.41	9.75	0.11	0.1	0.1	0.04
Total Assets	739.47	792.34	465.63	352.74	444.65	235.84
Accounts Payable	3.41	3.27	3.49	3.34	1.23	1.05
Accrued Expenses	25.46	33.84	22.03	12.84	12	8.46
Current Portion of Leases	1.5	1.45	1.61	1.45	1.75	1.33
Current Unearned Revenue	-	0.01	3.06	0.06	0.43	-
Other Current Liabilities	1.65	0.93	0.93	0.93	1.12	3.37
Total Current Liabilities	32.02	39.5	31.13	18.61	16.53	14.21
Long-Term Leases	1.93	2.36	0.93	2.59	1.3	2.15
Other Long-Term Liabilities	2.54	3.47	4.4	5.33	7.35	10.12
Total Liabilities	36.49	45.34	36.46	26.53	25.18	26.48
Common Stock	0.07	0.07	0.06	0.05	0.05	0.04
Additional Paid-In Capital	2,308	2,299	1,823	1,581	1,561	1,280
Retained Earnings	-1,609	-1,555	-1,397	-1,256	-1,144	-1,073
Comprehensive Income & Other	3.57	3.31	3.31	1.26	1.89	2.59
Shareholders' Equity	702.98	747.01	429.17	326.2	419.48	209.36
Total Liabilities & Equity	739.47	792.34	465.63	352.74	444.65	235.84
Total Debt	3.43	3.81	2.54	4.03	3.04	3.48
Net Cash (Debt)	669.86	721.47	421.06	300.92	405.21	190.94
Net Cash Growth	-18.48%	71.35%	39.92%	-25.74%	112.22%	214.43%
Net Cash Per Share	10.11	11.20	8.69	6.42	9.45	6.44
Filing Date Shares Outstanding	66.39	66.38	55.9	47.21	46.74	39.61
Total Common Shares Outstanding	66.38	66.37	55.88	47.2	46.73	39.6
Working Capital	661.74	707.66	400.57	299.08	394.31	183.64
Book Value Per Share	10.59	11.25	7.68	6.91	8.98	5.29
Tangible Book Value	675.79	719.82	401.98	299.01	392.29	178.67
Tangible Book Value Per Share	10.18	10.84	7.19	6.33	8.39	4.51
Machinery	-	17.39	16.01	15.26	14.51	14.61
Construction In Progress	-	0.14	0.79	0.5	0.63	0.34
Leasehold Improvements	-	10.29	9.65	9.61	9.53	10.1

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q